Narcolepsy Therapeutics Market Analysis By Type (Cataplexy and Without Cataplexy), By Product (Central Nervous System Stimulants, Sodium Oxybate, Tricyclic Antidepressants), And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
第三章Narcolepsy Therapeutics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market driver analysis
3.1.1.1 Increasing global prevalence of narcolepsy
3.1.1.2 Narcolepsy awareness programs and services
3.1.1.3 Presence of reimbursement policies regarding narcolepsy
3.1.2 Market restraint analysis
3.1.2.1 Adverse effects and risks related to narcolepsy drugs
3.1.2.2 Delayed diagnosis or misdiagnosis
3.3 Narcolepsy therapeutics - SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
3.4行业分析-波特的
第四章M嗜睡症疗法市场:类型Estimates & Trend Analysis
4.1 Narcolepsy Therapeutics Market: Type Movement Analysis
4.2 Narcolepsy With Cataplexy
4.2.1 Narcolepsy with cataplexy market, 2014 - 2025 (USD Million)
4.3 Narcolepsy Without Cataplexy
4.3.1 Narcolepsy without cataplexy market, 2014 - 2025 (USD Million)
4.4 Secondary Narcolepsy
4.4.1 Secondary narcolepsy market, 2014 - 2025 (USD Million)
Chapter 5 Narcolepsy Therapeutics Market: Product Estimates & Trend Analysis
5.1 Narcolepsy Therapeutics Market: Product Movement Analysis
5.2 Central nervous system stimulants
5.2.1 Central nervous system stimulants market, 2014 - 2025 (USD Million)
5.3 Sodium Oxybate
5.3.1 Sodium Oxybate market, 2014 - 2025 (USD Million)
5.4 Selective Serotonin Reuptake Inhibitor (SSRI)
5.4.1 Selective serotonin reuptake inhibitor market, 2014 - 2025 (USD Million)
5.5 Tricyclic Antidepressants
5.5.1 Tricyclic antidepressants market, 2014 - 2025 (USD Million)
5.6 Other Narcolepsy Drugs
5.6.1 Other narcolepsy drugs market, 2014 - 2025 (USD Million)
Chapter 6 Narcolepsy Therapeutics: Regional Estimates & Trend Analysis, by Drug Type
6.1 Narcolepsy Therapeutics Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America narcolepsy therapeutics market, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Europe narcolepsy therapeutics market, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific narcolepsy therapeutics market, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America narcolepsy therapeutics market, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 MEA narcolepsy therapeutics market, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.2.1 Addrenex Pharmaceuticals, Inc.
7.2.1.1 Company Overview
7.2.1.2 Product benchmarking
7.2.1.3 Strategic initiatives
7.2.2 Teva Pharmaceutical Industries Ltd.
7.2.2.1 Company overview
7.2.2.1 Financial performance
7.2.2.2 Product benchmarking
7.2.2.3 Strategic initiatives
7.2.3 Jazz Pharmaceuticals PLC
7.2.3.1 Company overview
7.2.3.2 Product benchmarking
7.2.3.3 Strategic initiatives
7.2.4 Graymark Healthcare, Inc.
7.2.4.1 Company overview
7.2.4.2 Product benchmarking
7.2.4.3 Strategic initiatives
7.2.5 Arena Pharmaceuticals, Inc.
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 BIOPROJET
7.2.6.1 Company overview
7.2.6.2 Product benchmarking
7.2.6.3 Strategic initiatives
7.2.7 Shire
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Ligand Pharmaceuticals, Inc.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives

List of Tables

TABLE 1 North America narcolepsy therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 2 North America narcolepsy therapeutics market, by product, 2014 - 2025 (USD Million)
TABLE 3 Europe narcolepsy therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 4 Europe narcolepsy therapeutics market, by product, 2014 - 2025 (USD Million)
TABLE 5 Asia Pacific narcolepsy therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 6 Asia Pacific narcolepsy therapeutics market, by product, 2014 - 2025 (USD Million)
TABLE 7 Latin America narcolepsy therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 8 Latin America narcolepsy therapeutics market, by product, 2014 - 2025 (USD Million)
TABLE 9 MEA narcolepsy therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 10 MEA narcolepsy therapeutics market, by product, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary, 2016
FIG. 6 Market trends & outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Market restrain relevance analysis (Current & future impact)
FIG. 11 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 12 Porter’s Five Forces Analysis
FIG. 13 Narcolepsy therapeutics market type outlook key takeaways
图14嗜睡症疗法市场:movem类型ent analysis
FIG. 15 Global narcolepsy with cataplexy market, 2014 - 2025 (USD Million)
FIG. 16 Global narcolepsy without cataplexy market, 2014 - 2025 (USD Million)
FIG. 17 Global secondary narcolepsy market, 2014 - 2025 (USD Million)
FIG. 18 Narcolepsy therapeutics market product outlook key takeaways
FIG. 19 Narcolepsy therapeutics market: Product movement analysis
FIG. 20 Global central nervous system stimulants market, 2014 - 2025 (USD Million)
FIG. 21 Global sodium Oxybate market, 2014 - 2025 (USD Million)
FIG. 22 Global selective serotonin reuptake inhibitor market, 2014 - 2025 (USD Million)
FIG. 23 Global tricyclic antidepressants market, 2014 - 2025 (USD Million)
FIG. 24 Global other narcolepsy drugs market, 2014 - 2025 (USD Million)
FIG. 25 Regional market place: Key takeaways
FIG. 26 Regional outlook, 2016 & 2025
FIG. 27 North America narcolepsy therapeutics market, 2014 - 2025 (USD Million)
FIG. 28 Europe narcolepsy therapeutics market, 2014 - 2025 (USD Million)
FIG. 29 Asia Pacific narcolepsy therapeutics market, 2014 - 2025 (USD Million)
FIG. 30 Latin America narcolepsy therapeutics market, 2014 - 2025 (USD Million)
FIG. 31 MEA narcolepsy therapeutics market, 2014 - 2025 (USD Million)
FIG. 32 Strategy framework